Join Us for the 2024 Colorado Privacy Summit on September 26th!

  • Contact Us
Businessman hold of global structure leveraging network technology to optimize performance and drive decision-making through data analytics. This allows for enhanced insights into market trends.
Blog

We leverage our deep clinical and commercial expertise, supported by an intensive, field-oriented research approach, to address the most complex business challenges. Explore our unique perspectives, innovative methodologies, and the critical insights we provide to help our clients navigate their most pressing issues. Explore our collection of Insights and Resources below to learn more about our unique approach at SAI Med Partners. 

Most Recent

Filter By

Clear all filters

All Resources

Blog

Market research teams are under more pressure than ever. Timelines are shrinking. Budgets are tightening. Expectations for certainty keep rising […]

Blog

Building on the China Pharmaceutical Innovation and Invention Index, which assesses the overall innovation strength of leading Chinese pharmaceutical companies, here […]

Blog

What it is: Synthetic Users built for pharma research: ​AI that behaves like real, emotional respondents​. Exclusive to Fulcrum Research and SAI. […]

Blog

In this episode of IDEA Collider, hosts Mike and Rick revisit a pivotal project from over a decade ago, the […]

Blog

Don’t Let Your Tracker Get Stale: An Interview with Lucy Robin By The Fulcrum Research Division Lucy Robin is one […]

Blog

In this episode of IDEA Collider, host Mike Rea speaks with Dr. Sekar Kathiresan, founder of Verve Therapeutics and now part of Eli Lilly, about […]

Blog

What Works, What Kills What, and Why It Matters By Mike Rea In pharmaceutical R&D, where billions ride on the […]

Blog

Minimizing Bias in Market Research: An Interview with Erik Coats By The Fulcrum Research Division Erik Coats is one of […]

Blog

Tuesday, November 4th, 2025, Boston, MA – Today, the annual Pharmaceutical Digital Innovation Index, a partnership between IDEA Pharma, a […]

Blog
In the healthcare regulation sphere, proposed EU-level joint clinical assessments (JCAs) have sparked debate in the pharmaceutical industry. A recent EFPIA report highlights concerns about the rigidity of the guidelines, particularly in oncology, and suggests revisions to ensure a more

Let’s Talk Business

Explore our Related Solutions: Delve Deeper

Gain further understanding of our range of related solutions and offerings by exploring each topic individually. 

Scroll to Top